{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05458778",
            "orgStudyIdInfo": {
                "id": "2022/04/16"
            },
            "organization": {
                "fullName": "Quanovate Tech Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "Detection of Urinary Human Chorionic Gonadotropin (hCG)",
            "officialTitle": "Detection of Urinary HCG During The Not Pregnancy and Pregnancy Cycles",
            "therapeuticArea": [
                "Women's Health"
            ],
            "study": "detection-of-urinary-human-chorionic-gonadotropin-hcg"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-04",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-06-29",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2023-10-31",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2023-10-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-07-04",
            "studyFirstSubmitQcDate": "2022-07-11",
            "studyFirstPostDateStruct": {
                "date": "2022-07-14",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-04-27",
            "lastUpdatePostDateStruct": {
                "date": "2023-05-01",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Quanovate Tech Inc.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": true,
            "isUnapprovedDevice": true
        },
        "descriptionModule": {
            "briefSummary": "The Mira Pregnancy Test is an over-the-counter urine hCG test intended for early detection of pregnancy. The test is indicated for use four days before the expected period. Throughout this study, volunteers with non-medical backgrounds were recruited to test hCG with urine samples using the Mira Pregnancy Test during the not pregnancy cycle or pregnancy cycle. To perform the study, a total number of more than 200 volunteers will be recruited to participate in the study.",
            "detailedDescription": "The studies include two parts, which are a lay user study and a urine samples test during the trying to conceive cycle.\n\nPart 1: Lay user study Part 2: Detection of hCG in Early Pregnancy Clinical Samples"
        },
        "conditionsModule": {
            "conditions": [
                "Pregnancy Detection"
            ]
        },
        "designModule": {
            "studyType": "OBSERVATIONAL",
            "patientRegistry": false,
            "designInfo": {
                "observationalModel": "COHORT",
                "timePerspective": "PROSPECTIVE"
            },
            "enrollmentInfo": {
                "count": 200,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Women who are trying to conceive",
                    "interventionNames": [
                        "Device: Daily test with urine by the product"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DEVICE",
                    "name": "Daily test with urine by the product",
                    "description": "Women perform the hCG test and share the test results",
                    "armGroupLabels": [
                        "Women who are trying to conceive"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Cognitive evaluation via survey and calculating the consistency",
                    "description": "The consistency between the lay-user test results and the actual test results",
                    "timeFrame": "From July 2022 to August 2022"
                },
                {
                    "measure": "The accuracy of data was expressed as per the Pregnancy Detection Rate",
                    "description": "The number of positive results on different days obtained by the user of the Mira pregnancy test is divided by the total number of women who confirmed pregnancy.",
                    "timeFrame": "From July 2022 to August 2022"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Female\n* Aged 18 and over\n* Willing to give informed consent\n* Willing to conduct a personal home pregnancy test and reveal their pregnancy status\n* Have a working smartphone\n\nExclusion Criteria:\n\n* Have a medical background or have been in a related industry/occupation\n* Volunteers who are unfit to participate in the research by the researcher\n* Used the investigational pregnancy test previously\n* Has a medical condition\n* Confirmed to be pregnant by a healthcare professional and beyond the first trimester (defined as last menstrual period (LMP) +13 weeks)",
            "healthyVolunteers": true,
            "sex": "FEMALE",
            "minimumAge": "18 Years",
            "maximumAge": "80 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ],
            "studyPopulation": "Include more than 200 worldwide women aged 18 and over taking part in this study.",
            "samplingMethod": "NON_PROBABILITY_SAMPLE"
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Zheng Yang, PhD",
                    "role": "CONTACT",
                    "phone": "+1 4125197085",
                    "email": "zyang@quanovate.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Ning Li, MS",
                    "affiliation": "Quanovate Tech Inc.",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Quanovate Tech Inc.",
                    "status": "RECRUITING",
                    "city": "San Ramon",
                    "state": "California",
                    "zip": "94583",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Zheng Yang, PhD",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.77993,
                        "lon": -121.97802
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M9168",
                    "name": "Chorionic Gonadotropin",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Repr",
                    "name": "Reproductive Control Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}